RD06-05 CART Cell
Autoimmune Diseases
The Children's Hospital of Zhejiang University School of MedicineEarly Phase 1Active
C
38/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 81/ 100
Competitive context
26 Active assets in the Autoimmune Diseases cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
total glucosides of paeony West China Hospital | Phase 4 | BB |
URSODEOXYCHOLIC ACID West China Hospital | Phase 4 | BB |
Cyclophosphamide The Children's Hospital of Zhejiang University School of Medicine | Phase 2 | B |
CEFADROXIL ANHYDROUS Mayo Clinic | Phase 4 | B |
Cephalexin Mayo Clinic | Phase 4 | B |
View all 35 →
Same molecule, other indications
RD06-05 CART Cell is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →